Health Discovery Corp (HDVY)

[dollardaze]

“Well, first of all, as we said, that any acquisition for us has to fit in strategically and has to make economic sense. And now you folks can realize why we waited to do the things that was really in line with our strategy to get into new platforms. Athena was a new platform for neurological disorders. Celera is a new platform for cardiovascular disease, but more importantly in discovery and development. And we will continue to invest money in these type of acquisitions as we go forward.”
Surya Mohapatra, - DGX Chairman, Chief Executive Officer, President and Chairman of Executive Committee